Healthy Living with Mild Cognitive Impairment (MCI): What’s Next in Alzheimer’s Detection and Treatment

Image
ellow road sign reading 'What’s Next' on a post beside a road stretching into the distance, with a blue sky and simple cloud illustrations in the background
9:30 am - 11:30 am
Online via Zoom and in person at various host sites across Wisconsin

Discover how blood tests and brain scans are transforming Alzheimer’s clinical trials. This session breaks down how researchers use these tools to identify the right study participants, track how treatments are working, and monitor safety. We’ll also explore newer areas of research, including inflammation and other brain changes, and discuss where the field is headed as easier, more accessible tests become available. The program will end with a Q&A session. Free and open to all.

Register to join us live online via Zoom from anywhere. Or visit adrc.wisc.edu/mci for details on attending the program in person at one of 10 locations across Wisconsin. 

Guest presenter: Henrik Zetterberg, MD, PhD, UW–Madison School of Medicine and Public Health. Zetterberg is a world-renowned authority on biomarker research and currently focuses on developing biomarkers for Alzheimer’s and related dementias, as well as diagnostic tests and new monitoring tools for these diseases. Learn more about his work in On Wisconsin magazine.

Hosts: Nathaniel Chin, MD, and Jennifer McAlister, BA.

Learn more: "Healthy Living with MCI program empowers participants across Wisconsin, globally"

About the series
The Healthy Living with Mild Cognitive Impairment (MCI) series is a free support and education program about brain health and living well with MCI. Classes offer attendees guidance and science-backed strategies for living and coping with memory and thinking changes. Nathaniel Chin, MD, a memory clinic doctor with UW Health and medical director of the Wisconsin Alzheimer's Disease Research Center (ADRC), is the medical director and host of the series. Participation is free and available to attend at a host site or online via Zoom.

What is mild cognitive impairment? 
MCI is an intermediate stage between the expected cognitive decline of normal aging and the more pronounced decline of dementia. Learn more about MCI on our website.

New site